Sernova Biotherapeutics (SVA.TO) Q4 2024 Earnings

23DecConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.04
-0.03
-0.03
-0.02

Details

Expected EPS
-0.030926037899999998
Actual EPS
-0.03608037755
Surprise EPS
-0.01
Surprise Percent
+16.67%

Description

Sernova Biotherapeutics (SVA.TO) has reported earnings of -0.03608037755 per share for Q4 2024.

0 Comments

Share your thoughts